Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.32
-0.01 (-0.75%)
At close: Jun 26, 2025, 3:59 PM
-0.75% (1D)
| Bid | 1.31 |
| Market Cap | 14.75M |
| Revenue (ttm) | 155.93K |
| Net Income (ttm) | -42.64M |
| EPS (ttm) | -5.76 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | 3.28 |
| Analyst | Buy |
| Ask | 1.32 |
| Volume | 95,366 |
| Avg. Volume (20D) | 2,354,841 |
| Open | 1.34 |
| Previous Close | 1.33 |
| Day's Range | 1.32 - 1.36 |
| 52-Week Range | 0.65 - 26.25 |
| Beta | 0.85 |
About CTXR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTXR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTXR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-22.63%
Citius Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
2 weeks ago
+60.99%
Citius Pharmaceuticals shares are trading higher after the company announced it entered into a distribution services agreement with Cardinal Health
11 months ago · newsfilecorp.com
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second of a two-part series looking at biotech/biopharma ...
11 months ago · newsfilecorp.com
Biopharma Stocks Transformative Innovation for the Future of HealthVancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first of a two-part series looking at transformative innov...
